tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:NOVA Stock Latest News

Company AnnouncementsNovo Nordisk’s Semaglutide Study: A Potential Game-Changer for NASH Treatment
9h ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s Haemophilia A Study: A New Era with Mim8?
9h ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s New Study Targets Kidney Disease: What Investors Need to Know
3d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s CagriSema Study: A Potential Game-Changer for Diabetes and Weight Management
3d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s CagriSema Study: A New Frontier in Diabetes Treatment
3d ago
NOVA
PremiumCompany AnnouncementsNovo Nordisk’s CagriSema Study: A Potential Game-Changer for Diabetes Treatment?
3d ago
NOVA
Premium
Company Announcements
Novo Nordisk’s New Clinical Study: A Potential Game-Changer for Diabetes and Obesity Treatment
3d ago
NOVA
Premium
Company Announcements
Novo Nordisk’s Ziltivekimab Study: A Potential Game-Changer for Heart Failure Treatment?
3d ago
NOVA
PremiumCompany Announcements
Novo Nordisk Completes Study on New Diabetes Treatment IcoSema
4d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s Mim8 Study: A Potential Game-Changer in Haemophilia Treatment
4d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s Turoctocog Alfa Study: A Closer Look at Haemophilia A Treatment in Iraq
4d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s Etavopivat Study: A Long-term Solution for Blood Disorders?
4d ago
NOVA
PremiumCompany AnnouncementsNovo Nordisk’s Promising Phase 3 Study on Etavopivat for Sickle Cell Disease
4d ago
NOVA
Premium
Company Announcements
Novo Nordisk’s Diabetes Study Completion: A Potential Market Game-Changer
4d ago
NOVA
Premium
Company Announcements
Novo Nordisk’s Compassionate Use of Concizumab: A Game-Changer for Haemophilia Treatment?
4d ago
NOVA
PremiumCompany Announcements
Novo Nordisk Completes Study on New Semaglutide Tablet Formulations
4d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s SELECT-LIFE Study: Long-term Insights into Obesity Treatment
4d ago
NOVA
PremiumCompany Announcements
Novo Nordisk’s Groundbreaking Study on Weekly Growth Hormone Treatment Completes
4d ago
NOVA
Avidity, Phathom mentioned as potential takeout targets at Needham
PremiumThe Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
4d ago
BMY
NVO
PremiumCompany AnnouncementsNovo Nordisk’s New Study on Kidney Disease Treatment: A Potential Game Changer?
5d ago
NOVA
Premium
Company Announcements
Novo Nordisk’s New Study on NNC0519-0130: A Potential Game-Changer for Diabetes Treatment?
5d ago
NOVA
Premium
Company Announcements
Novo Nordisk’s CagriSema Study Completes: Implications for Diabetes Treatment Market
5d ago
NOVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >